• Hear about the revisions to GVP Module V with the DSRU’s training day

    The newly updated GVP Module V now includes clarification of the scope of RMPs in relation to important identified or potential risks and missing information. Join us to hear from speakers including members of the EMA team who wrote the revised GVP Module V and updated the RMP template, as well as QPPV and other pharma staff. […]

    >Continue reading
  • DSRU Consultancy launched!

    We’re delighted to announce the launch of DSRU Consultancy: Pharmacovigilance, Pharmacoepidemiology and Risk Management. DSRU Consultancy provides advice on strategies, study designs and options for post-marketing Pharmacovigilance, Pharmacoepidemiology and Risk Management Planning. This initiative builds on the DSRU’s vast experience in studying a wide range medicines and working with companies of all sizes. The DSRU has […]

    >Continue reading
  • Report published on Signal Detection Conference

    The meeting report has just been published for our 9th Biennial Signal Detection Conference, which took place in June. The report details some of the highlights and themes of the event, including Signal Detection in the Age of Big Data, new methodologies and updates on well-established approaches. DSRU Signal Detection Conferences have built up a […]

    >Continue reading
  • DSRU’s 9th Signal Detection Conference is a great success!

    Our biennial Signal Detection Conferences have built up a loyal following in the pharmacovigilance community since the first conference in 2001. It was a pleasure to see many familiar faces at last week’s 9th Signal Detection Conference, as well as to welcome many newcomers. The majority of delegates attended the pre-conference tutorial day, which had been redesigned […]

    >Continue reading